Categories: Uncategorized

Dr Reddy’s Laboratories expecting first lot of Sputnik V vaccine by May end

After receiving approval from DGCI for restricted emergency use of Covid-19 vaccine Sputnik V, Dr Reddy’s Laboratories on Tuesday said it expects a lot of stock from Russian Direct Investment Fund by May end.

In September 2020, Dr Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India.

Medically Speaking Team

Recent Posts

One Sleepless Night Can Weaken Your Immunity and Trigger Inflammation

Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…

2 days ago

Thick Heart Syndrome: A Silent Threat to Millions in India

Heart disease remains one of the leading causes of death worldwide, and in India, cardiovascular…

2 days ago

Delhi Sees Surge in H1N1 and Influenza B Cases

Delhi is witnessing a sharp rise in flu cases, particularly Influenza B and H1N1 (commonly…

2 days ago

Woman Dies During MRI Scan Due to Medical Negligence

In early February 2025, a tragic incident occurred in Eluru, Andhra Pradesh, where a 61-year-old…

2 days ago

Holi and Eye Safety: Protect Your Vision During Festivities

Holi, the festival of colors, is one of the most vibrant and joyous celebrations in…

3 days ago

FDA Recalls Popular Skincare Products Over Cancer-Causing Chemical

In a major development, the U.S. Food and Drug Administration (FDA) has issued recalls for…

3 days ago